General Biologicals Corporation financial reports, General Biologicals Corporation annual revenue in 2024. When does General Biologicals Corporation report revenue?
General Biologicals Corporation total revenue, net income and dynamics of changes in Taiwan new dollar today
General Biologicals Corporation current income and income for the latest reporting periods. Net income of General Biologicals Corporation today amounted to 32 360 500 $. The dynamics of net income of General Biologicals Corporation has changed by 0 $ in recent years. General Biologicals Corporation online financial report chart. The financial report chart on our website displays information by dates from 30/09/2018 to 31/12/2020. General Biologicals Corporation financial report on the graph shows the dynamics of assets.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2020
5 078 235 791 $
+157.57 % ↑
1 056 699 767 $
-
30/09/2020
5 078 235 791 $
+157.57 % ↑
1 056 699 767 $
-
30/06/2020
2 691 244 718 $
+31.28 % ↑
-41 976 717 $
-
31/03/2020
2 691 244 718 $
+31.28 % ↑
-41 976 717 $
-
30/06/2019
2 050 034 447 $
-
-339 373 022 $
-
31/03/2019
2 050 034 447 $
-
-339 373 022 $
-
31/12/2018
1 971 599 539 $
-
-777 181 527 $
-
30/09/2018
1 971 599 539 $
-
-777 181 527 $
-
Show:
to
General Biologicals Corporation financial report charts
The latest dates of General Biologicals Corporation financial statements available online: 30/09/2018, 30/09/2020, 31/12/2020. The dates of financial statements are strictly regulated by law and financial statements. The latest financial report of General Biologicals Corporation is available online for such a date - 31/12/2020. Gross profit General Biologicals Corporation is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit General Biologicals Corporation is 85 212 000 $
General Biologicals Corporation quarterly report dates
Cost of revenue General Biologicals Corporation is the total cost of producing and distributing of products and services of a company. Cost of revenue General Biologicals Corporation is 70 304 500 $ Total revenue General Biologicals Corporation refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue General Biologicals Corporation is 155 516 500 $ Operating income General Biologicals Corporation is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income General Biologicals Corporation is 22 753 000 $
Net income General Biologicals Corporation is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income General Biologicals Corporation is 32 360 500 $ Current assets General Biologicals Corporation is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets General Biologicals Corporation is 608 908 000 $ Total assets General Biologicals Corporation refers to the total amount of assets owned by a person or entity. Total assets General Biologicals Corporation is 833 281 000 $
31/12/2020
30/09/2020
30/06/2020
31/03/2020
30/06/2019
31/03/2019
31/12/2018
30/09/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 782 512 648 $
2 782 512 648 $
1 316 462 337 $
1 316 462 337 $
1 149 584 070 $
1 149 584 070 $
881 282 479 $
881 282 479 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 295 723 143 $
2 295 723 143 $
1 374 782 381 $
1 374 782 381 $
900 450 377 $
900 450 377 $
1 090 317 060 $
1 090 317 060 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
5 078 235 791 $
5 078 235 791 $
2 691 244 718 $
2 691 244 718 $
2 050 034 447 $
2 050 034 447 $
1 971 599 539 $
1 971 599 539 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
742 976 462 $
742 976 462 $
-34 939 780 $
-34 939 780 $
-301 771 941 $
-301 771 941 $
-706 763 176 $
-706 763 176 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 056 699 767 $
1 056 699 767 $
-41 976 717 $
-41 976 717 $
-339 373 022 $
-339 373 022 $
-777 181 527 $
-777 181 527 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
428 012 305 $
428 012 305 $
243 549 859 $
243 549 859 $
239 859 957 $
239 859 957 $
264 023 917 $
264 023 917 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 335 259 329 $
4 335 259 329 $
2 726 184 498 $
2 726 184 498 $
2 351 806 388 $
2 351 806 388 $
2 678 362 715 $
2 678 362 715 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
19 883 281 832 $
19 883 281 832 $
7 066 031 714 $
7 066 031 714 $
5 003 245 880 $
5 003 245 880 $
4 759 973 580 $
4 759 973 580 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
27 209 957 774 $
27 209 957 774 $
12 485 942 634 $
12 485 942 634 $
11 052 987 152 $
11 052 987 152 $
9 214 207 758 $
9 214 207 758 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
11 448 720 978 $
11 448 720 978 $
2 680 860 746 $
2 680 860 746 $
990 689 706 $
990 689 706 $
1 193 242 468 $
1 193 242 468 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
5 005 009 196 $
5 005 009 196 $
4 642 288 564 $
4 642 288 564 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
8 127 090 790 $
8 127 090 790 $
5 952 040 504 $
5 952 040 504 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
73.53 %
73.53 %
64.60 %
64.60 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
22 353 165 084 $
22 353 165 084 $
5 514 705 482 $
5 514 705 482 $
2 925 896 362 $
2 925 896 362 $
3 262 167 254 $
3 262 167 254 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-154 943 230 $
-154 943 230 $
-104 688 724 $
-104 688 724 $
Last revenue report of General Biologicals Corporation was 31/12/2020. According to last financial report total revenue in General Biologicals Corporation was 5 078 235 791 Taiwan new dollar and changed by +157.57% since last year. Net income in General Biologicals Corporation was 1 056 699 767 $ in last quartal, net income changes to 0%.
Current cash General Biologicals Corporation - the sum of all of the cash a company has on the date of report. Current cash General Biologicals Corporation is 350 607 000 $
General Biologicals Corporation stocks data
4117.TWO stock price
General Biologicals Corporation stock price today, 4117.TWO stock quote.
